IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Latest 424B4 SEC Filings
Prospectus [Rule 424(b)(4)]
OSI PHARMACEUTICALS INC, 424B4, 2000-11-01
ISTA PHARMACEUTICALS INC, 424B4, 2000-08-22
HUMAN GENOME SCIENCES INC, 424B4, 1999-12-13
TECHNICLONE CORP/DE/, 424B4, 1999-08-16
CYTOGEN CORP, 424B4, 1999-03-02
TECHNICLONE CORP/DE/, 424B4, 1999-01-19
TECHNICLONE CORP/DE/, 424B4, 1998-12-17
VYSIS INC, 424B4, 1998-02-05
DIGENE CORP, 424B4, 1997-10-15
INTERNATIONAL ISOTOPES INC, 424B4, 1997-08-14
HYSEQ INC, 424B4, 1997-08-11
BIOSITE DIAGNOSTICS INC, 424B4, 1997-02-12
BOSTON BIOMEDICA INC, 424B4, 1996-10-31
DIGENE CORP, 424B4, 1996-05-22
AVIGEN INC \DE, 424B4, 1996-05-22
ONCOGENE SCIENCE INC, 424B4, 1996-03-15
GENOME THERAPEUTICS CORP, 424B4, 1996-02-20
FAQ
|
Privacy
|
Terms Of Service
|
Contact
© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission
